Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD

After controlling for a number of potentially confounding factors, multiple-inhaler users had more exacerbations, a higher risk of exacerbation, and higher healthcare resource utilization and costs compared to single-inhaler users.